Safety and Efficacy of Diacerein 1% Ointment for Subjects With Epidermolysis Bullosa Simplex (EBS)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mary Spellman, MD
Castle Creek Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Premier Specialists Pty Ltd; the Church
Kogarah, New South Wales, Australia
- Eb House Austria
Salzburg, Austria
- Hopital Necker-Enfants Malades
Paris, Cedex, France
- Hopital Saint Louis
Paris, Cedex, France
- Chu de Nice - Hopital de L'Archet Ii - Service de Dermatologie
Nice, France
- University Medical Center Freiburg
Freiburg im Breisgau, Germany
- Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
- University Medical Center Groningen
Groningen, Netherlands
- Great Ormond Street Hospital
London, England, United Kingdom
- St. Thomas' Hospital - St Johns Institute of Dermatology
London, United Kingdom
- Phoenix Childrens Hospital
Phoenix, Arizona, United States
- Stanford University
Palo Alto, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Ann and Robert H. Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
- Northwestern University
Chicago, Illinois, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- University of Missouri Healthcare
Columbia, Missouri, United States
- Stony Brook University Medical Center
Stony Brook, New York, United States
- University of North Carolina - Chapel Hill
Chapel Hill, North Carolina, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Medical University of South Carolina (musc)
Charleston, South Carolina, United States
- Children'S Hospital of San Antonio ; Texas Dermatology and Laser Specialists
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jun 2017
- Primary completion
- 15 Oct 2018
- Completion
- 31 Oct 2018
- Last update posted
- 5 Nov 2019
- Registered enrollment
- 54
- Registry id
- NCT03154333
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.